Sign In

Login

Password

Forgot Password ? Sign Up

Vancomycin (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vancomycin" in German language version.

refsWebsite
Global rank German rank
17doi.org
2nd place
3rd place
9nih.gov
4th place
7th place
2google.de
2,106th place
139th place
1mdpi.com
2,912th place
1,242nd place
1bund.de
2,092nd place
164th place
1oup.com
485th place
715th place
1lww.com
2,769th place
2,484th place

bund.de (Global: 2,092nd place; German: 164th place)

bfr.bund.de

doi.org (Global: 2nd place; German: 3rd place)

  • Heather C. Losey, Mark W. Peczuh, Zhong Chen, Ulrike S. Eggert, Steven D. Dong, Istvan Pelczer, Daniel Kahne, Christopher T. Walsh: Tandem action of glycosyltransferases in the maturation of vancomycin and teicoplanin aglycones: novel glycopeptides. In: Biochemistry. Band 40, Nr. 15, 2001, S. 4745–4755, doi:10.1021/bi010050w.
  • Santiago Alvarez-Arango, S. Michelle Ogunwole, Thomas D. Sequist, Caitlin M. Burk, Kimberly G. Blumenthal: Vancomycin Infusion Reaction — Moving beyond “Red Man Syndrome”. In: New England Journal of Medicine. Band 384, Nr. 14, 8. April 2021, S. 1283–1286, doi:10.1056/NEJMp2031891.
  • Vanthida Huang, Nicola A. Clayton, Kimberly H. Welker: Glycopeptide Hypersensitivity and Adverse Reactions. In: Pharmacy. Band 8, Nr. 2, 21. April 2020, S. 70, doi:10.3390/pharmacy8020070, PMID 32326261, PMC 7357119 (freier Volltext) – (mdpi.com [abgerufen am 1. Mai 2021]).
  • A. E. van den Bogaard, N. Bruinsma and E. E. Stobberingh: The effect of banning avoparcin on VRE carriage in The Netherlands. In: Journal of Antimicrobial Chemotherapy. Band 46, Nr. 1. The British Society for Antimicrobial Chemotherapy, 2000, S. 146–148, doi:10.1093/jac/46.1.146 (oup.com [abgerufen am 20. Februar 2011]).
  • Shigenobu Matsuzaki, Mohammad Rashel, Jumpei Uchiyama, Shingo Sakurai, Takako Ujihara: Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. In: Journal of Infection and Chemotherapy. Band 11, Nr. 5, 2005, S. 211–219, doi:10.1007/s10156-005-0408-9.
  • Udo Lorenz, Knut Ohlsen, Helge Karch, Michael Hecker, Arnulf Thiede: Human antibody response during sepsis against targets expressed by methicillin resistant Staphylococcus aureus. In: FEMS Immunology & Medical Microbiology. Band 29, Nr. 2, 1. Oktober 2000, S. 145–153, doi:10.1111/j.1574-695X.2000.tb01517.x.
  • Michael P. Motley, Kasturi Banerjee, Bettina C. Fries: Monoclonal antibody-based therapies for bacterial infections. In: Current Opinion in Infectious Diseases. Band 32, Nr. 3, Juni 2019, S. 210–216, doi:10.1097/QCO.0000000000000539, PMID 30950853, PMC 7050834 (freier Volltext) – (lww.com [abgerufen am 22. Juli 2022]).
  • Jeffrey L. Fox: Antimicrobial peptides stage a comeback. In: Nature Biotechnology. Band 31, Nr. 5, 1. Mai 2013, S. 379–382, doi:10.1038/nbt.2572.
  • Nurit Beyth, Yael Houri-Haddad, Avi Domb, Wahid Khan, Ronen Hazan: Alternative Antimicrobial Approach: Nano-Antimicrobial Materials. In: Evidence-Based Complementary and Alternative Medicine. Band 2015, 16. März 2015, S. e246012, doi:10.1155/2015/246012, PMID 25861355, PMC 4378595 (freier Volltext).
  • Mark A. T. Blaskovich, Karl A. Hansford, Yujing Gong, Mark S. Butler, Craig Muldoon: Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria. In: Nature Communications. Band 9, Nr. 1, Dezember 2018, S. 22, doi:10.1038/s41467-017-02123-w, PMID 29295973, PMC 5750218 (freier Volltext).
  • Venkateswarlu Yarlagadda, Padma Akkapeddi, Goutham B. Manjunath, Jayanta Haldar: Membrane Active Vancomycin Analogues: A Strategy to Combat Bacterial Resistance. In: Journal of Medicinal Chemistry. Band 57, Nr. 11, 12. Juni 2014, S. 4558–4568, doi:10.1021/jm500270w.
  • Dongliang Guan, Feifei Chen, Yunguang Qiu, Bofeng Jiang, Likun Gong: Sulfonium, an Underestimated Moiety for Structural Modification, Alters the Antibacterial Profile of Vancomycin Against Multidrug‐Resistant Bacteria. In: Angewandte Chemie International Edition. Band 58, Nr. 20, 13. Mai 2019, S. 6678–6682, doi:10.1002/anie.201902210.
  • Zhi-Chen Wu, Dale L. Boger: Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin. In: Accounts of Chemical Research. Band 53, Nr. 11, 17. November 2020, S. 2587–2599, doi:10.1021/acs.accounts.0c00569, PMID 33138354, PMC 7674238 (freier Volltext).
  • Alexandra Antonoplis, Xiaoyu Zang, Melanie A. Huttner, Kelvin K. L. Chong, Yu B. Lee: A Dual-Function Antibiotic-Transporter Conjugate Exhibits Superior Activity in Sterilizing MRSA Biofilms and Killing Persister Cells. In: Journal of the American Chemical Society. Band 140, Nr. 47, 28. November 2018, S. 16140–16151, doi:10.1021/jacs.8b08711, PMID 30388366, PMC 6430714 (freier Volltext).
  • F. Umstätter, C. Domhan, T. Hertlein, K. Ohlsen, E. Mühlberg, C. Kleist, S. Zimmermann, B. Beijer, K. D. Klika, U. Haberkorn, W. Mier, P. Uhl: Vancomycin Resistance Is Overcome by Conjugation of Polycationic Peptides. In: Angewandte Chemie. Band 59, Nummer 23, 06 2020, S. 8823–8827, doi:10.1002/anie.202002727, PMID 32190958, PMC 7323874 (freier Volltext).
  • Lewis F. Neville, Itamar Shalit, Peter A. Warn, Marc H. Scheetz, Jiuzhi Sun: In Vivo Targeting of Escherichia coli with Vancomycin-Arginine. In: Antimicrobial Agents and Chemotherapy. Band 65, Nr. 4, 18. März 2021, S. e02416–20, doi:10.1128/AAC.02416-20, PMID 33468474, PMC 8097466 (freier Volltext).
  • Alexandra Antonoplis, Xiaoyu Zang, Tristan Wegner, Paul A. Wender, Lynette Cegelski: Vancomycin–Arginine Conjugate Inhibits Growth of Carbapenem-Resistant E. coli and Targets Cell-Wall Synthesis. In: ACS Chemical Biology. Band 14, Nr. 9, 20. September 2019, S. 2065–2070, doi:10.1021/acschembio.9b00565, PMID 31479234, PMC 6793997 (freier Volltext).

google.de (Global: 2,106th place; German: 139th place)

books.google.de

lww.com (Global: 2,769th place; German: 2,484th place)

journals.lww.com

  • Michael P. Motley, Kasturi Banerjee, Bettina C. Fries: Monoclonal antibody-based therapies for bacterial infections. In: Current Opinion in Infectious Diseases. Band 32, Nr. 3, Juni 2019, S. 210–216, doi:10.1097/QCO.0000000000000539, PMID 30950853, PMC 7050834 (freier Volltext) – (lww.com [abgerufen am 22. Juli 2022]).

mdpi.com (Global: 2,912th place; German: 1,242nd place)

nih.gov (Global: 4th place; German: 7th place)

ncbi.nlm.nih.gov

  • Vanthida Huang, Nicola A. Clayton, Kimberly H. Welker: Glycopeptide Hypersensitivity and Adverse Reactions. In: Pharmacy. Band 8, Nr. 2, 21. April 2020, S. 70, doi:10.3390/pharmacy8020070, PMID 32326261, PMC 7357119 (freier Volltext) – (mdpi.com [abgerufen am 1. Mai 2021]).
  • Michael P. Motley, Kasturi Banerjee, Bettina C. Fries: Monoclonal antibody-based therapies for bacterial infections. In: Current Opinion in Infectious Diseases. Band 32, Nr. 3, Juni 2019, S. 210–216, doi:10.1097/QCO.0000000000000539, PMID 30950853, PMC 7050834 (freier Volltext) – (lww.com [abgerufen am 22. Juli 2022]).
  • Nurit Beyth, Yael Houri-Haddad, Avi Domb, Wahid Khan, Ronen Hazan: Alternative Antimicrobial Approach: Nano-Antimicrobial Materials. In: Evidence-Based Complementary and Alternative Medicine. Band 2015, 16. März 2015, S. e246012, doi:10.1155/2015/246012, PMID 25861355, PMC 4378595 (freier Volltext).
  • Mark A. T. Blaskovich, Karl A. Hansford, Yujing Gong, Mark S. Butler, Craig Muldoon: Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria. In: Nature Communications. Band 9, Nr. 1, Dezember 2018, S. 22, doi:10.1038/s41467-017-02123-w, PMID 29295973, PMC 5750218 (freier Volltext).
  • Zhi-Chen Wu, Dale L. Boger: Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin. In: Accounts of Chemical Research. Band 53, Nr. 11, 17. November 2020, S. 2587–2599, doi:10.1021/acs.accounts.0c00569, PMID 33138354, PMC 7674238 (freier Volltext).
  • Alexandra Antonoplis, Xiaoyu Zang, Melanie A. Huttner, Kelvin K. L. Chong, Yu B. Lee: A Dual-Function Antibiotic-Transporter Conjugate Exhibits Superior Activity in Sterilizing MRSA Biofilms and Killing Persister Cells. In: Journal of the American Chemical Society. Band 140, Nr. 47, 28. November 2018, S. 16140–16151, doi:10.1021/jacs.8b08711, PMID 30388366, PMC 6430714 (freier Volltext).
  • F. Umstätter, C. Domhan, T. Hertlein, K. Ohlsen, E. Mühlberg, C. Kleist, S. Zimmermann, B. Beijer, K. D. Klika, U. Haberkorn, W. Mier, P. Uhl: Vancomycin Resistance Is Overcome by Conjugation of Polycationic Peptides. In: Angewandte Chemie. Band 59, Nummer 23, 06 2020, S. 8823–8827, doi:10.1002/anie.202002727, PMID 32190958, PMC 7323874 (freier Volltext).
  • Lewis F. Neville, Itamar Shalit, Peter A. Warn, Marc H. Scheetz, Jiuzhi Sun: In Vivo Targeting of Escherichia coli with Vancomycin-Arginine. In: Antimicrobial Agents and Chemotherapy. Band 65, Nr. 4, 18. März 2021, S. e02416–20, doi:10.1128/AAC.02416-20, PMID 33468474, PMC 8097466 (freier Volltext).
  • Alexandra Antonoplis, Xiaoyu Zang, Tristan Wegner, Paul A. Wender, Lynette Cegelski: Vancomycin–Arginine Conjugate Inhibits Growth of Carbapenem-Resistant E. coli and Targets Cell-Wall Synthesis. In: ACS Chemical Biology. Band 14, Nr. 9, 20. September 2019, S. 2065–2070, doi:10.1021/acschembio.9b00565, PMID 31479234, PMC 6793997 (freier Volltext).

oup.com (Global: 485th place; German: 715th place)

academic.oup.com